2. Signaling Pathways
  3. Cell Cycle/DNA Damage
  4. HMG Family
  5. HMGB Isoform

HMGB

 

HMGB Related Products (1):

Cat. No. Product Name Effect Purity
  • HY-P9928A
    Alirocumab (anti-PCSK9)
    		98.24%
    Alirocumab (anti-PCSK9) is an anti-PCSK9 human monoclonal antibody. Alirocumab (anti-PCSK9) inhibits PCSK9. Alirocumab (anti-PCSK9) reduces NLRP3 inflammasome, regulates Nrf2/HO-1, HMGB1/NF-κB and Fractalkine/CX3CR1. Alirocumab (anti-PCSK9) increases the ability of the liver to bind LDL-cholesterol (LDL-C) and reduces levels of LDL-C in blood. Alirocumab (anti-PCSK9) improves atherosclerosis and inflammation.